Literature DB >> 9305598

ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphocytic leukemia.

H Cavé1, V Cacheux, S Raynaud, G Brunie, M Bakkus, P Cochaux, C Preudhomme, J L Laï, E Vilmer, B Grandchamp.   

Abstract

The presence of ETV6 deletions was investigated in 215 children with acute lymphoblastic leukemia (ALL) using the loss of heterozygosity (LOH) approach. We used four intragenic or juxtagenic microsatellite markers to detect allelic deletions. In this series of unselected patients, LOH of ETV6 markers was found in 23% of cases (6% of T-ALL and 26% of B lineage ALL) confirming that chromosome 12p12-13 deletions represent a major genetic alteration in childhood ALL, frequently missed by cytogenetic analysis. The presence of a t(12;21)(p13;q22) was studied by RT-PCR and/or FISH in a total of 134 patients (125 B lineage ALL, nine T-ALL) including 42 cases with LOH. Thirty-four out of 44 patients (77%) for whom a t(12;21) was observed displayed LOH of the ETV6 markers. When associated with a t(12;21), ETV6 is very likely to be the target of deletions as indicated by the detection of intragenic deletions in three patients. Although deletion of ETV6 and t(12;21) were associated in most patients, in eight cases (six B lineage and two T-ALL) LOH was detected at the ETV6 locus without ETV6-AML1 hybrid RNA. FISH studies conducted in five of these eight patients confirmed the absence of translocation involving ETV6. In such patients, the other allele of ETV6 could be disrupted by either a small deletion, a point mutation, or an epigenetic modification and it will be of interest to study the structure and expression of the remaining allele of ETV6 in these cases. Alternatively, a tumor suppressor gene located close to ETV6 and CDKN1B could be the target of deletions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9305598     DOI: 10.1038/sj.leu.2400798

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  14 in total

1.  Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein.

Authors:  R Fenrick; J M Amann; B Lutterbach; L Wang; J J Westendorf; J R Downing; S W Hiebert
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

Review 2.  Role of RUNX1 in hematological malignancies.

Authors:  Raman Sood; Yasuhiko Kamikubo; Paul Liu
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

3.  ETV6 mutation in a cohort of 970 patients with hematologic malignancies.

Authors:  Qinrong Wang; Shasha Dong; Hong Yao; Lijun Wen; Huiying Qiu; Llili Qin; Liang Ma; Suning Chen
Journal:  Haematologica       Date:  2014-07-04       Impact factor: 9.941

Review 4.  DNA copy number losses in human neoplasms.

Authors:  S Knuutila; Y Aalto; K Autio; A M Björkqvist; W El-Rifai; S Hemmer; T Huhta; E Kettunen; S Kiuru-Kuhlefelt; M L Larramendy; T Lushnikova; O Monni; H Pere; J Tapper; M Tarkkanen; A Varis; V M Wasenius; M Wolf; Y Zhu
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

5.  Low-level expression of ETV6/TEL in patients with Myelodysplastic syndrome.

Authors:  Tetsuya Yamagata; Yuka Nakamura; Kinuko Mitani
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

6.  The acetyltransferase 60 kDa trans-acting regulatory protein of HIV type 1-interacting protein (Tip60) interacts with the translocation E26 transforming-specific leukaemia gene (TEL) and functions as a transcriptional co-repressor.

Authors:  Iver Nordentoft; Poul Jørgensen
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

7.  Molecular cytogenetic analysis of gene rearrangements in childhood acute lymphoblastic leukemia.

Authors:  Hee Yeon Woo; Dae Won Kim; Hyosoon Park; Ki Woong Seong; Hong Hoe Koo; Sun Hee Kim
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

8.  The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells.

Authors:  Anthony M Ford; Chiara Palmi; Clara Bueno; Dengli Hong; Penny Cardus; Deborah Knight; Giovanni Cazzaniga; Tariq Enver; Mel Greaves
Journal:  J Clin Invest       Date:  2009-03-16       Impact factor: 14.808

9.  ETV6-RUNX1 Rearrangement in Tunisian Pediatric B-Lineage Acute Lymphoblastic Leukemia.

Authors:  Abir Gmidène; Hatem Elghezal; Hlima Sennana; Yosra Ben Youssef; Balkiss Meddeb; Moez Elloumi; Abderrahim Khlif; Ali Saad
Journal:  Adv Hematol       Date:  2009-12-22

10.  Connections between ETV6-modulated genes: identification of shared features.

Authors:  Gino Boily; Patrick Beaulieu; Jasmine Healy; Daniel Sinnett
Journal:  Cancer Inform       Date:  2008-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.